Lifeward (NASDAQ:LFWD) Releases Quarterly Earnings Results

Lifeward (NASDAQ:LFWD) announced its quarterly earnings data on Friday. The company reported ($1.44) EPS for the quarter, missing analysts’ consensus estimates of ($0.78) by ($0.66), FiscalAI reports. Lifeward had a negative net margin of 141.28% and a negative return on equity of 235.86%. The company had revenue of $5.43 million for the quarter, compared to analyst estimates of $7.24 million.

Lifeward Trading Down 29.0%

Lifeward stock traded down $1.66 during midday trading on Friday, reaching $4.06. The stock had a trading volume of 30,374 shares, compared to its average volume of 14,890. The firm’s fifty day simple moving average is $6.42 and its two-hundred day simple moving average is $6.87. Lifeward has a twelve month low of $3.81 and a twelve month high of $9.61. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.33 and a quick ratio of 1.77. The firm has a market cap of $11.49 million, a price-to-earnings ratio of -0.24 and a beta of 0.55.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on LFWD shares. Weiss Ratings raised Lifeward from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, October 9th. Citigroup reaffirmed a “buy” rating on shares of Lifeward in a research report on Friday, August 21st. HC Wainwright reissued a “buy” rating and issued a $10.00 price target on shares of Lifeward in a research note on Friday, August 21st. Finally, Zacks Research upgraded Lifeward from a “strong sell” rating to a “hold” rating in a report on Monday, July 27th. Two investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $10.00.

Lifeward Company Profile

Lifeward Ltd. (NASDAQ: LFWD) is a medical technology company focused on developing and commercializing wearable robotic systems designed to help people with mobility impairments stand, walk and participate in rehabilitation. The company was formerly known as ReWalk Robotics and adopted the Lifeward name in 2024. Lifeward’s principal product line is the ReWalk Personal Exoskeleton, a battery-powered wearable robotic device intended to enable individuals with lower-limb disabilities, including those resulting from spinal cord injury, to walk with the assistance of crutches or other support.